Global Heart Attack Diagnostics Market, By Test (Electrocardiogram (ECG), Blood Test, Chest X-Ray, Echocardiogram, Coronary Catheterization (Angiogram), Exercise Stress Test, Magnetic Resonance Imaging (MRI)) By End-user (Hospitals, Specialty Clinics, Pathology) and opportunities and forecast 2020-2027
Heart Attack Diagnostics Market Overview
The demand for heart attack diagnostic devices has increased due to the rising need for continuous monitoring of individuals and accessibility for a patient. Incidence of diabetes and hypertension increases globally due to unhealthy lifestyles are likely to drive the growth of the heart attack diagnosis market. For instance, according to the Centers for Disease Control and Prevention, about 735,000 Americans suffer from a heart attack every year.
Besides, the increasing geriatric population and increasing obesity among the population, contribute to the noteworthy growth for the market. For instance, according to the World Health Organization (WHO), in 2019, more than 38.0 million children were overweight. Obesity and overweight are also on the rise in low- and middle-income regions. For instance, in African countries, the number of overweight populations increased by 24% since 2000. As a result, obesity will stimulate the incidences of cardiovascular problems. ultimately drive the growth of the heart attack diagnosis market.
However, higher investments in R&D and technological advancement in the healthcare sector will provide lucrative growth opportunities to the market in the coming years.
Heart Attack Diagnostics Market Segment Overview
ECG has a larger application and contributes to the incredible growth of the market. ECG is one of the most commonly used medical tests for the diagnosis of heart attacks. ECG monitoring systems, event monitors, implantable loop recorders, cardiac telemetry, and ECG data management solutions are the modern techniques contributing to the growth of the ECG market. However, the low Medicare reimbursements provided for the peripatetic cardiac outpatient telemetry electrocardiogram (ECG) is expected to hinder the growth of this segment in the forecast period. The troponin blood test segment has remarkable market growth. This is due to the rapid, accurate results within a short period.
Heart Attack Diagnostics Regional Overview
North America is anticipated to dominate the market in the global heart attack diagnostics market during the forecast period. Increasing diabetic and obesity population is the key aspect positively affecting growth of the heart attack diagnostic market in the region. Furthermore, the market of the Asia Pacific is projected to grow at the fastest rate owing to rising death rates because of heart diseases in the region.
Recently, in June 2020, Novo Nordisk NOVOb.CO has agreed to buy AstraZeneca spin-off Corvidia Therapeutics for an initial $725 million as the world's largest diabetes drugmaker seeks to expand into cardiovascular disease treatments.
Heart Attack Diagnostics Market, Key Players
· Abbott Laboratories · Beckman Coulter · Bio-Rad Laboratories Inc. · Siemens Healthcare Diagnostics · GE Healthcare · Life Sign LLC · Hitachi Medical Systems · Schiller AG. · Midmark Corporation · Koninklijke Philips N.V. · Bionet Co., Ltd. · Welch Allyn · Toshiba Medical Systems Corporation · Mortara Instrument · F. Hoffmann-La Roche Ltd.
Heart Attack Diagnostics Market Segmentation
Heart Attack Diagnostics Market, By Test
· Electrocardiogram (ECG) · Blood Test · Chest X-Ray · Echocardiogram · Coronary Catheterization (Angiogram) · Exercise Stress Test · Magnetic Resonance Imaging (MRI)
Heart Attack Diagnostics Market, By End-user
· Hospitals · Specialty Clinics · Pathology
Heart Attack Diagnostics market, By Region
North America
US
Canada
Europe
UK
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
South America
Brazil
Argentina
Rest of South America
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Key Emerging Trends – For Major Countries
4.2. Latest Technological Advancement
4.3. Regulatory Landscape
4.4. Industry SWOT Analysis
4.5. Porters Five Forces Analysis
5. Global Heart Attack Diagnostics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Test
5.2.1. Electrocardiogram (ECG)
5.2.2. Blood Test
5.2.3. Chest X-Ray
5.2.4. Echocardiogram
5.2.5. Coronary Catheterization (Angiogram)
5.2.6. Exercise Stress Test
5.2.7. Magnetic Resonance Imaging (MRI)
5.3. Market Analysis, Insights and Forecast – By End-user
5.3.1. Hospitals
5.3.2. Specialty Clinics
5.3.3. Pathology
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Latin America
5.4.3. Europe
5.4.4. Asia Pacific
5.4.5. Middle East and Africa
6. North America Heart Attack Diagnostics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Test
6.2.1. Electrocardiogram (ECG)
6.2.2. Blood Test
6.2.3. Chest X-Ray
6.2.4. Echocardiogram
6.2.5. Coronary Catheterization (Angiogram)
6.2.6. Exercise Stress Test
6.2.7. Magnetic Resonance Imaging (MRI)
6.3. Market Analysis, Insights and Forecast – By End-user
6.3.1. Hospitals
6.3.2. Specialty Clinics
6.3.3. Pathology
6.4. Market Analysis, Insights and Forecast – By Country
6.4.1. U.S.
6.4.2. Canada
7. Latin America Heart Attack Diagnostics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast – By Test
7.2.1. Electrocardiogram (ECG)
7.2.2. Blood Test
7.2.3. Chest X-Ray
7.2.4. Echocardiogram
7.2.5. Coronary Catheterization (Angiogram)
7.2.6. Exercise Stress Test
7.2.7. Magnetic Resonance Imaging (MRI)
7.3. Market Analysis, Insights and Forecast – By End-user
7.3.1. Hospitals
7.3.2. Specialty Clinics
7.3.3. Pathology
7.4. Insights and Forecast – By Country
7.4.1. Brazil
7.4.2. Mexico
7.4.3. Rest of Latin America
8. Europe Heart Attack Diagnostics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast – By Test
8.2.1. Electrocardiogram (ECG)
8.2.2. Blood Test
8.2.3. Chest X-Ray
8.2.4. Echocardiogram
8.2.5. Coronary Catheterization (Angiogram)
8.2.6. Exercise Stress Test
8.2.7. Magnetic Resonance Imaging (MRI)
8.3. Market Analysis, Insights and Forecast – By End-user
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Pathology
8.4. Market Analysis, Insights and Forecast – By Country
8.4.1. UK
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Rest of Europe
9. Asia Pacific Heart Attack Diagnostics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
9.1. Key Findings / Summary
9.2. Market Analysis, Insights and Forecast – By Test
9.2.1. Electrocardiogram (ECG)
9.2.2. Blood Test
9.2.3. Chest X-Ray
9.2.4. Echocardiogram
9.2.5. Coronary Catheterization (Angiogram)
9.2.6. Exercise Stress Test
9.2.7. Magnetic Resonance Imaging (MRI)
9.3. Market Analysis, Insights and Forecast – By End-user
9.3.1. Hospitals
9.3.2. Specialty Clinics
9.3.3. Pathology
9.4. Market Analysis, Insights and Forecast – By Country
9.4.1. China
9.4.2. India
9.4.3. Japan
9.4.4. Australia
9.4.5. South East Asia
9.4.6. Rest of Asia Pacific
10. Middle East & Africa Heart Attack Diagnostics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
10.1. Key Findings / Summary
10.2. Market Analysis, Insights and Forecast – By Test
10.2.1. Electrocardiogram (ECG)
10.2.2. Blood Test
10.2.3. Chest X-Ray
10.2.4. Echocardiogram
10.2.5. Coronary Catheterization (Angiogram)
10.2.6. Exercise Stress Test
10.2.7. Magnetic Resonance Imaging (MRI)
10.3. Market Analysis, Insights and Forecast – By End-user
10.3.1. Hospitals
10.3.2. Specialty Clinics
10.3.3. Pathology
10.4. Market Analysis, Insights and Forecast – By Country
10.4.1. GCC
10.4.2. South Africa
10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Company Market Share Analysis, 2018
11.2. Key Industry Developments
11.3. Company Profile
11.4. Abbott Laboratories
11.4.1. Business Overview
11.4.2. Segment 1 & Service Offering
11.4.3. Overall Revenue
11.4.4. Geographic Presence
11.4.5. Recent Development
*Similar details will be provided for the following companies
11.5. Beckman Coulter
11.6. Bio-Rad Laboratories Inc.
11.7. Siemens Healthcare Diagnostics
11.8. GE Healthcare
11.9. Life Sign LLC
11.10. Hitachi Medical Systems
11.11. Schiller AG.
11.12. Midmark Corporation
11.13. Koninklijke Philips N.V.
11.14. Bionet Co., Ltd.
11.15. Welch Allyn
11.16. Toshiba Medical Systems Corporation
11.17. Mortara Instrument
List of Figures
Figure 1: Global Heart Attack Diagnostics Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
Figure 2: Global Heart Attack Diagnostics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 3: Global Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 4: Global Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 5: Global Heart Attack Diagnostics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 6: Global Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 7: Global Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 8: Global Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 9: Global Heart Attack Diagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 10: Global Heart Attack Diagnostics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 11: Global Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 12: Global Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 13: Global Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 14: Global Heart Attack Diagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 15: Global Heart Attack Diagnostics Market Value (USD Billion), by Region, 2019 & 2027
Figure 16: North America Heart Attack Diagnostics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 17: North America Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 18: North America Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 19: North America Heart Attack Diagnostics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 20: North America Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 21: North America Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 22: North America Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 23: North America Heart Attack Diagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 24: North America Heart Attack Diagnostics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 25: North America Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 26: North America Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 27: North America Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 28: North America Heart Attack Diagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 29: North America Heart Attack Diagnostics Market Forecast (USD Billion), by U.S., 2016-2027
Figure 30: North America Heart Attack Diagnostics Market Forecast (USD Billion), by Canada, 2016-2027
Figure 31: Latin America Heart Attack Diagnostics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 32: Latin America Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 33: Latin America Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 34: Latin America Heart Attack Diagnostics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 35: Latin America Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 36: Latin America Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 37: Latin America Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 38: Latin America Heart Attack Diagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 39: Latin America Heart Attack Diagnostics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 40: Latin America Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 41: Latin America Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 42: Latin America Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 43: Latin America Heart Attack Diagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 44: Latin America Heart Attack Diagnostics Market Forecast (USD Billion), by Brazil, 2016-2027
Figure 45: Latin America Heart Attack Diagnostics Market Forecast (USD Billion), by Mexico, 2016-2027
Figure 46: Latin America Heart Attack Diagnostics Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
Figure 47: Europe Heart Attack Diagnostics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 48: Europe Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 49: Europe Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 50: Europe Heart Attack Diagnostics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 51: Europe Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 52: Europe Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 53: Europe Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 54: Europe Heart Attack Diagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 55: Europe Heart Attack Diagnostics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 56: Europe Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 57: Europe Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 58: Europe Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 59: Europe Heart Attack Diagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 60: Europe Heart Attack Diagnostics Market Forecast (USD Billion), by U.K., 2016-2027
Figure 61: Europe Heart Attack Diagnostics Market Forecast (USD Billion), by Germany, 2016-2027
Figure 62: Europe Heart Attack Diagnostics Market Forecast (USD Billion), by France, 2016-2027
Figure 63: Europe Heart Attack Diagnostics Market Forecast (USD Billion), by Italy, 2016-2027
Figure 64: Europe Heart Attack Diagnostics Market Forecast (USD Billion), by Spain, 2016-2027
Figure 65: Europe Heart Attack Diagnostics Market Forecast (USD Billion), by Russia, 2016-2027
Figure 66: Europe Heart Attack Diagnostics Market Forecast (USD Billion), by Rest of Europe, 2016-2027
Figure 67: Asia Pacific Heart Attack Diagnostics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 68: Asia Pacific Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 69: Asia Pacific Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 70: Asia Pacific Heart Attack Diagnostics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 71: Asia Pacific Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 72: Asia Pacific Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 73: Asia Pacific Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 74: Asia Pacific Heart Attack Diagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 75: Asia Pacific Heart Attack Diagnostics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 76: Asia Pacific Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 77: Asia Pacific Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 78: Asia Pacific Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 79: Asia Pacific Heart Attack Diagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 80: Asia Pacific Heart Attack Diagnostics Market Forecast (USD Billion), by China, 2016-2027
Figure 81: Asia Pacific Heart Attack Diagnostics Market Forecast (USD Billion), by India, 2016-2027
Figure 82: Asia Pacific Heart Attack Diagnostics Market Forecast (USD Billion), by Japan, 2016-2027
Figure 83: Asia Pacific Heart Attack Diagnostics Market Forecast (USD Billion), by Australia, 2016-2027
Figure 84: Asia Pacific Heart Attack Diagnostics Market Forecast (USD Billion), by Southeast Asia, 2016-2027
Figure 85: Asia Pacific Heart Attack Diagnostics Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
Figure 86: Middle East & Africa Heart Attack Diagnostics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 87: Middle East & Africa Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 88: Middle East & Africa Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 89: Middle East & Africa Heart Attack Diagnostics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 90: Middle East & Africa Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 91: Middle East & Africa Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 92: Middle East & Africa Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 93: Middle East & Africa Heart Attack Diagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 94: Middle East & Africa Heart Attack Diagnostics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 95: Middle East & Africa Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 96: Middle East & Africa Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 97: Middle East & Africa Heart Attack Diagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 98: Middle East & Africa Heart Attack Diagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 99: Middle East & Africa Heart Attack Diagnostics Market Forecast (USD Billion), by GCC, 2016-2027
Figure 100: Middle East & Africa Heart Attack Diagnostics Market Forecast (USD Billion), by South Africa, 2016-2027
Figure 101: Middle East & Africa Heart Attack Diagnostics Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027
List of Tables
Table 1: Global Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 2: Global Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 3: Global Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 4: Global Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Region, 2016-2027
Table 5: North America Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 6: North America Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 7: North America Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 8: North America Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 9: Europe Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 10: Europe Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 11: Europe Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 12: Europe Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 13: Latin America Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 14: Latin America Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 15: Latin America Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 16: Latin America Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 17: Asia Pacific Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 18: Asia Pacific Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 19: Asia Pacific Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 20: Asia Pacific Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 21: Middle East & Africa Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 22: Middle East & Africa Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 23: Middle East & Africa Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 24: Middle East & Africa Heart Attack Diagnostics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
